Acute renal failure in COVID-19

Acute kidney injury (AKI) is a frequent complication in coronavirus disease 2019 (COVID-19). It is often linked to progressive respiratory failure and is associated with increased morbidity and mortality. The AKI is presumably of multifactorial origin, whereby direct viral infestation of the kidneys also seems to be involved. Specific treatment procedures for AKI associated with COVID-19 are currently missing. In addition, the role of extracorporeal procedures in the treatment of COVID-19 could so far not be clarified. Latest data indicate persistent loss of renal function following COVID-19-associated AKI. Therefore, a re-evaluation of renal function following recovery from COVID-19 should be recommended.

Automated summary

AKI is a common and serious complication in patients with COVID-19, which lacks specific treatment. Direct viral infestation of the kidneys may cause persistent loss of renal function in patients. Therefore, a re-evaluation of renal function following recovery from COVID-19 is recommended.